prostate cancer | Expertise | 0 pages | source: NutritionFacts.org | Added Aug 07, 2019
Which is healthier? Vegetables that help block cell growth
That doesn’t mean some veggies aren’t better than others. Some of these vegetables target multiple cancers at the same time. So, using this groundbreaking new data, let’s play “Which is healthier?”
Imagine you’re standing in line at one of those custom made-to-order salad places, where you get to choose your lettuce, choose your toppings, then choose your dressing. Let’s assume you don’t have a strong family history of any particular cancer, and so, aren’t trying to hone in on avoiding one tumor over any other.
First, let’s choose our lettuce. Boston, endive, radicchio, romaine, or spinach? Which is healthier? Out of the five, spinach is #1 against breast cancer—remember, the farther down, the better it is at slowing down these cancer cells. #1 against brain tumors, #1 against kidney cancer, #1 against lung cancer, and pediatric brain tumors—that’s why we need to feed our kids spinach! #1 against pancreatic cancer, prostate cancer, and stomach cancer.
Now it’s not #1 overall; there are 16 vegetables more powerful at stopping stomach cancer growth than spinach. But out of those five salad greens, spinach wins out across the board, against every cancer type tested.
What if the salad place said they were out of spinach, though? Which comes in second, out of the four left to choose from? For breast cancer, radicchio is #2. Against brain tumors? Radicchio. Kidney cancer? Radicchio. Radicchio, romaine, radicchio, radicchio, and radicchio. So, overall, out of those choices for greens, radicchio is second healthiest.
Back to the menu. Next, we get to choose four toppings. Now, there’s a long line of people behind you, all staring at us to make our choice. We don’t have time to ponder and pick the four absolute best, but we can at least make a guess as to roughly where on the graph they are.
Yes or no? According to this amazing new data, do carrots slow down cancer cell growth rates more than 50%? Yes or no? The answer is no. No, no, no, no, no, no, and no. So, shredded carrots aren’t going to make our top toppings choice.
What about shredded beets? Yes or no? Yes. Super yes! Brain tumor? Just beet it. Kidney cancer is a no; close to 50%, but not quite there. But then yes, yes, yes, yes, yes. So, overall, yes for beets.
Are we putting cucumber on our salad? As tasty as they may be, no. For most cancers it suppressed tumor cell growth less than 50%.
What about tomatoes? No tomatoes, either.
What about a potato? You can actually choose potatoes for your salad. Yes or no? No potatoes, either.
Wait a second; no iceberg lettuce, carrots, cucumbers, tomatoes, potatoes—that’s all people eat! That’s the problem. Even people eating their vegetables, aren’t really eating their vegetables. The majority of veggies people commonly eat have little effect.
Cutting to the chase: the line at the salad place is now out the door at this point. In this study, there was one clear winner. One vegetable that completely 100% stopped cancer growth in seven out of the eight tumor lines. One of the most important findings of the year. Which vegetable was it? Was it bok choy? Broccoli, Brussels sprouts, fiddlehead ferns, garlic, kale, or red cabbage?
#1 against breast cancer? Garlic. #1 against brain tumors? Garlic.#2 against kidney cancer: Garlic. Lung cancer? Garlic. Childhood brain tumors? Garlic. Pancreatic cancer? Garlic. Prostate cancer and stomach cancer? Garlic. So might I suggest a garlicky salad dressing?
But wait. Is it just that garlic is toxic to all cells? Yes, it stops the growth of cancer cells, but maybe it stops the growth of healthy cells, too? That wouldn’t be good. They tested for that. The black bars are the cancer cells; the white bars are the normal cells. As you can see, garlic slams cancer cells, but doesn’t touch normal cells, and the same thing with pretty much all the vegetables. They’re selective; they go after the cancer cells, but leave the normal cells alone. Veggies are amazing.
Now, if you didn’t pick garlic, and instead chose one of those others, you probably weren’t far off. The two best families of vegetables for cancer prevention are the cruciferous vegetables, like broccoli, kale, cabbage, and the allium family vegetables—like garlic, onions, and leeks. Let me just run through this one last time to highlight this important concept.
Starting from the beginning. Cruciferous vegetables in green; allium family vegetables in yellow. So what I want you to notice is the clustering of colors over to the right side, which illustrates the power of these two superfood classes of vegetables—whether for breast cancer, brain cancer, kidney cancer, lung cancer, or brain cancer.
Interestingly, you’ll notice that bok choy is often the kind of odd one out—apparently the least healthy of the cruciferous vegetables. Pancreatic cancer, prostate cancer, and finally, stomach cancer. So you know all those recipes that start with garlic and onions, and then throw you in some greens? That is the way to eat.
The researchers conclude: “The inclusion of cruciferous and Allium [family] vegetables in the diet is essential for effective dietary-based chemopreventive [or cancer-preventive] strategies.”
erectile dysfunction | Research | Treatment | 10 pages | source: The journal of sexual medicine | Added Aug 06, 2019
Arginine and erectile dysfunction
This study looked at the safety and effectiveness of arginine in the treatment of erectile dysfunction (ED). It concluded that arginine is safe and effective in treating mild or moderate ED.
prostate cancer | Research | Treatment | 10 pages | source: International journal of urology: official journal of the Japanese Urological Association | Added Aug 05, 2019
Long term outcomes of docetaxel-based chemotherapy with dexamethasone for advanced prostate cancer
This article investigated the safety and effectiveness of docetaxel (Taxotere)-based chemotherapy in combination with dexamethasone (Decadron) for the treatment of castration-resistant prostate cancer (CRPC). The authors concluded that this treatment combination is a safe and effective treatment option for advanced prostate cancer.
erectile dysfunction | Research | Treatment | 10 pages | source: The world journal of men's health | Added Aug 04, 2019
Extracorporeal shock wave therapy: can it treat symptoms in men with Peyronie’s disease?
This study investigated the effectiveness of extracorporeal shock wave therapy (ESWT) in men with Peyronie’s disease (PD).
They found that ESWT is safe and effective in these patients.
erectile dysfunction | Research | Treatment | 10 pages | source: Current urology reports | Added Jul 30, 2019
Treatment options for erectile dysfunction
This study reviewed current non-surgical treatment options for erectile dysfunction (ED).
prostate cancer | Clinical Trial | Added Jul 30, 2019
Searching for men with castration-resistant prostate cancer to test combination of secondary hormone therapies
This phase 2 trial aims to evaluate the side effects and how well abiraterone acetate (Zytiga), niclosamide (Niclocide), and prednisone work in treating patients with hormone-resistant prostate cancer. The main outcome to be investigated is treatment response. The trial is recruiting in Sacramento (California), USA.
prostate cancer | Research | 10 pages | source: BJU international | Added Jul 29, 2019
What is the risk for bladder and rectal cancer in patients previously treated for localized prostate cancer?
This study investigated the rate of bladder cancer (BC) and rectal cancer (RC) after localized prostate cancer (PC) treatment.
They found that brachytherapy (BT) increased the risk of BC and RC in these patients.
prostate cancer | Clinical Trial | Added Jul 28, 2019
Looking for men with prostate cancer, resistant to male hormone suppression, to be treated with medication and radiotherapy
This study evaluates the effectiveness of medication and focal radiation in the treatment of prostate cancer resistant male hormone suppression. The main outcome to be measured in this trial is the number of patients whose cancer does not grow or spread and who are alive at 18 months after treatment. This trial is taking place in Ann Arbor, Michigan, United States.
erectile dysfunction | Clinical Trial | Added Jul 27, 2019
Searching for men with mild or moderate erectile dysfunction to test low-intensity shock wave therapy
This study aims to compare two similar treatment protocols to deliver low-intensity shock wave therapy for erectile dysfunction. The main outcome to be investigated is the improvement in erectile function. The trial is recruiting in Miami (Florida), USA.
erectile dysfunction | Clinical Trial | Added Jul 27, 2019
Searching for men with symptoms of an overactive bladder and/or erectile dysfunction to test a new drug treatment (mirabegron).
The aim of the trial is to examine the effect of mirabegron (Myrbetriq) treatment on symptoms of overactive bladder and erectile dysfunction (ED – difficulty achieving and maintaining an erection). The main outcome to be measured is a change in erectile function over time. This trial is being conducted in Baltimore, Maryland.